Rhinocort Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Rhinocort General Information
Description
Rights to Rhinocort Aqua. The asset is a nasal spray indicated for allergic and non-allergic rhinitis, inflammation of the inside of the nose and for the treatment of nasal polyps like swelling of the nasal lining.
Contact Information
Website
www.rhinocort.comCorporate Office
- Cambridge
- England, United Kingdom
Corporate Office
- Cambridge
- England, United Kingdom
Rhinocort Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Rhinocort Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Rhinocort FAQs
-
Where is Rhinocort headquartered?
Rhinocort is headquartered in Cambridge, United Kingdom.
-
What industry is Rhinocort in?
Rhinocort’s primary industry is Buildings and Property.
-
Is Rhinocort a private or public company?
Rhinocort is a Private company.
-
What is the current valuation of Rhinocort?
The current valuation of Rhinocort is
. -
What is Rhinocort’s current revenue?
The current revenue for Rhinocort is
. -
Who are Rhinocort’s investors?
AstraZeneca has invested in Rhinocort.
-
When was Rhinocort acquired?
Rhinocort was acquired on 05-Dec-2016.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »